Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-25-019011
Filing Date
2025-05-30
Accepted
2025-05-30 16:43:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 rvph20250512_424b5.htm 424B5 451855
2 rvph01.jpg GRAPHIC 8960
3 rvph20240130_s3img001.jpg GRAPHIC 4143
  Complete submission text file 0001437749-25-019011.txt   471306
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276848 | Film No.: 251011710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)